Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish a Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery

to develop innovative solutions that help improve lives worldwide. Headquartered in Crystal Lake, Illinois, Aptar employs 14,000 dedicated people across 20 countries. For more information please visit, http://www.aptar.com.

Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop to Improve Efficiency and Consistency in Gene Therapy Manufacturing

of the existing portfolio while simplifying virus filtration processes. Its compact design accommodates workflows using 0.12 m² or 0.3 m² Planova™ 35N virus-removal filters. The VANTIJ® simplifies small-scale Planova™ virus filtration while...

PHC Launched MTR-OPC1-PW Interface Board in September to Strengthen Data Linkage Between Equipment and Customer Systems

referred to as "PHC") Life Science Division Biomedica Business Group (PHCbi) is pleased to announce that the MTR-OPC-OPC1-PW, an interface board compatible with the OPC UA ®(*2) standard, will be launched in September to strengthen data...

Avenacy Launched Cyclophosphamide for Injection, USP in the U.S. Market

are unable to tolerate adrenocorticosteroid therapy. Avenacy’s Cyclophosphamide for Injection, USP is available in 500 mg, 1 gram, and 2 gram single-dose vials, with one vial per carton. In line with Avenacy’s mission to champion patient safety and...

5th MENA Congress for Rare Diseases 2026

aspects related to rare diseases and including presentations, panel discussions, and workshops delivered by more than 150 speakers, including more than 50 international experts coming from more than 20 different countries. In addition, the congress...

New HCPCS Billing Code Enables Medicare Reimbursement for Lasix® ONYU When Furnished Incident to a Physician’s Service

Medicare & Medicaid Services (CMS) has established a new Healthcare Common Procedure Coding System (HCPCS) Level II code, J1946 ("Injection, furosemide (Lasix ONYU), 1 mg"), for its product Lasix® ONYU (furosemide injection). The code was published...

Jarrow Formulas® Launches Gut & Protein Optimizer and NMN 300 mg to Support Protein Absorption, Cellular Energy, and Healthy Aging

the protein conversation has largely focused on quantity: how many grams of protein consumers can add to their diets.1 Jarrow Formulas® Gut & Protein Optimizer takes a different approach by helping consumers get more from every gram they already...

Abbott Launched the First and Only Ready-to-Feed Liquid Infant Formula Made with Whole Milk in the U.S. at a Price Similar to Its Existing Similac Powdered Formula

or exceed industry regulations for infant formula testing. About Similac® Similac has been feeding babies for more than 100 years. Backed by Abbott's science and research, Similac is committed to supporting parents with high-quality infant...

Karyopharm Files Supplemental New Drug Application with FDA for XPOVIO® (Selinexor) in Combination with Ruxolitinib for the Treatment of Myelofibrosis

with ruxolitinib compared to placebo plus ruxolitinib in JAKi-naïve myelofibrosis patients with platelet counts >100 x 109/L (N=353). Patients were randomized 2-to-1 to the selinexor arm. The co-primary endpoints for this trial are spleen volume...

Choose Health Launches Comprehensive At-Home Liver Function Test Featuring 20+ Biomarkers and Clinical Risk Scores

Its trajectory can often be changed: AASLD guidance indicates 3 to 5% weight loss can improve steatosis, with above 10% needed to improve steatohepatitis and fibrosis What does the Choose Health Comprehensive Liver Function Test measure? The test...

Abbott receives FDA authorization for the world’s first dual glucose-ketone sensing technology for people with diabetes

Abbott the global healthcare leader, today announced U.S. Food and Drug Administration (FDA) authorization of its Libre Duo 10 Day system, the world's first dual glucose‑ketone sensing technology. The new biowearable is designed to alert people...

U.S. FDA Approves Ziihera® (zanidatamab-hrii), With or Without Tislelizumab Plus Chemotherapy, for the First-Line Treatment of HER2-Positive Advanced Gastroesophageal Adenocarcinoma

for people with HER2+ advanced GEA. Ziihera is now the first and only bispecific HER2-targeted antibody combined with a PD-1 inhibitor and chemotherapy approved for all HER2+ advanced GEA patients, regardless of PD-L1 status, establishing a new...

European Commission Approves DAYBU® (Trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms Associated with Rett Syndrome in the European Union

About Rett Syndrome Rett syndrome is a rare, complex, neurodevelopmental disorder and occurs in approximately one of every 10,000 to 15,000 female births worldwide.1-3 A child with Rett syndrome generally exhibits an early period of apparently...

Upsher-Smith Expands Neurology Portfolio with the Launch of Glatiramer Acetate Injection

Upsher-Smith Laboratories, LLC a subsidiary of Bora Pharmaceuticals Co., Ltd. (6472.TW and BORAY.OTCQX), announced the recent launch of Glatiramer Acetate Injection in 20 mg/mL and 40 mg/mL strengths, adding to the Company's portfolio of complex...

Dunbar Pharma Brings First Plant-Derived Dronabinol API to the UK Market Through IPS Pharma

precision for individualised prescribing. CBPMs manufactured with WaterClear THC™ are supplied in 5 mg and 10 mg capsules, a 25 mg/mL oral dose spray, and a 25 mg/mL oily dropper solution. These may be prescribed where clinically appropriate under...

Former DePuy Synthes U.S. President Joins Peptilogics Board

Tim Czartoski, orthopedic executive and former president of DePuy Synthes U.S. and most recently president of U.S. Surgical and Global R&D at Enovis, has joined the Peptilogics board of directors. His background in leading large orthopedic device...

PanTRKare™ Is Officially Approved as the Companion Diagnostic for VELMARTO® (Eratrectinib)

NMPA granted approval to Geneseeq's PanTRKare™ NTRK1/2/3 Gene Fusion Detection Kit as a companion diagnostic for VELMARTO® (Eratrectinib), a next‑generation highly selective TRK inhibitor independently developed by Vcare PharmaTech. The approval...

Bruker and Atinary Technologies Join Forces to Accelerate the Future of Self-Driving Laboratories

About Atinary Technologies Atinary Technologies is the pioneer of Self-Driving Labs®, a term its founders coined in 2017. Atinary's mission is to augment humans with AI and robotics to drive a Moore's Law of Discovery, exponentially accelerating...

Neurolief Advances Veteran Mental Health and Migraine Care With New VA Contract for Prescription Neuromodulation

often classified as having treatment-resistant depression, comprise approximately 30% of the overall MDD population1 and represent a significant unmet medical need. "Too many people I treat have carried depression for years, moving from one...

AVANTIK Appoints Jeffrey Waldman as Chief Executive Officer

two decades of healthcare leadership experience and a strong track record of building high-performing businesses. During a 19-year career at Henry Schein, he spearheaded strategic, operational and commercial initiatives across key businesses. As...